Literature DB >> 8058315

Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides.

S M Picksley1, B Vojtesek, A Sparks, D P Lane.   

Abstract

The function of p53 is modulated by binding to a number of cellular and viral proteins, such as MDM2 and SV40 large T antigen. An initial immunochemical characterization of the p53-MDM2 complex in a rat fibroblast cell line (Clone 6) suggested that the anti-p53 monoclonal antibody Bp53-19 failed to immunoprecipitate the complex, and only recognized a fraction of the available p53 protein. Following the recent identification of the Bp53-19 epitope at the N-terminal end of p53, in the vicinity of where MDM2 protein was known to bind, we investigated the possibility that Bp53-19 might identify a region of p53 that interacts with MDM2 protein. MDM2 was found to bind with great specificity to short synthetic peptides derived from the N-terminus of p53. Several p53 synthetic peptides libraries, and an alanine substitution series at the optimal binding site, were used to establish the MDM2 binding site, in fine detail, to the sequence TFSGLW (aa 18-23) in mouse and TFSDLW in man (aa 18-23). The key residues required for MDM2 binding are almost identical to those required for the monoclonal antibody Bp53-19 to bind and this region of p53 is recognised by many other anti-p53 antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058315

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

1.  Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.

Authors:  M J O'Connor; H Zimmermann; S Nielsen; H U Bernard; T Kouzarides
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

3.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

5.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Functional interaction between DP-1 and p53.

Authors:  T S Sørensen; R Girling; C W Lee; J Gannon; L R Bandara; N B La Thangue
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.

Authors:  Sanjeev Shangary; Ke Ding; Su Qiu; Zaneta Nikolovska-Coleska; Joshua A Bauer; Meilan Liu; Guoping Wang; Yipin Lu; Donna McEachern; Denzil Bernard; Carol R Bradford; Thomas E Carey; Shaomeng Wang
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.

Authors:  Ayesha Elias; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2013-03-27       Impact factor: 4.436

10.  The p53-MDM2/MDMX axis - A chemotype perspective.

Authors:  Kareem Khoury; Grzegorz M Popowicz; Tad A Holak; Alexander Dömling
Journal:  Medchemcomm       Date:  2011       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.